Data / Form D filings / AlloTRx Bio Inc.
AlloTRx Bio Inc.: Form D filing
AlloTRx Bio Inc., a biotechnology company in Pittsburgh, PA, filed a Form D with the SEC in 2026. The latest, on August 24, 2026, reports $500,000 sold of a $3 million offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 7070 BENNINGTON WOODS DR, Pittsburgh, PA, 15237
- Phone
- (201) 989-7999
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2023
- Revenue range
- No Revenues
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2151424
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Aug 24, 2026 | New notice | $3,000,000 | $500,000 | $2,500,000 | 1 | Aug 17, 2026 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Jatinkumar Machhi | Executive Officer, Director, Promoter | President, CEO, and Founder of AlloTRx Bio Inc. (the "Company") |
| Nagesh Reddy Arra | Director | Investor Director / Representative of Source Code Technologies LLC (the "Investor") |
Other biotechnology companies in Pennsylvania that filed recently
- BioLattice Ophthalmics, Inc, $1.8 million · Oct 28, 2026
- Myris Therapeutics, Inc. $500,000 · Oct 14, 2026
- Praeventix, Inc. $5.6 million · Sep 10, 2026
- Plowshare Therapies LLC $6.7 million · Aug 31, 2026
- Noveome Biotherapeutics, Inc. $6.8 million · Aug 27, 2026
- Aposture Surgical Corp $87,000 · Aug 13, 2026
Every Form D from the week of Aug 24, 2026 · All recent filings in Pennsylvania · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what AlloTRx Bio Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.